New in: Product launches from Junlebao, MD Pharma, Nestle China

By Tingmin Koe

- Last updated on GMT

New product launches from Junlebao, MD Pharma, Nestle China

Related tags Junlebao Nestlé Dsm

This round-up features the new product launches from nutrition firms across Asia-Pacific, including Chinese brand Junlebao’s lactoferrin infant formula, Singapore firm MD Pharma’s ‘faster-acting’ vitamin D, and new launches from Nestle China.
Immune focus: China’s Junlebao increases lactoferrin content in latest infant formula launch

China’s Junlebao Dairy Group has launched a new infant formula, which is said to contain one of the highest lactoferrin content in the market at 468mg/100g of milk powder.

Prior to the launch, the firm has been selling products containing 100mg of lactoferrin in per 100 grams of milk powder, with the goal of increasing lactoferrin content to 2.5g/100g eventually.

This is done to mimic the amount of lactoferrin found in mature breastmilk, according to Celia Ning, who joined the company as the director of Nutrition Research Institute in April.

Singapore firm MD Pharmaceuticals and DSM develop ‘faster-acting’ vitamin D supplement to boost immunity

MD Pharmaceuticals, a Singapore-based healthcare distributor and marketer, has developed a new vitamin D supplement with DSM, which is said to be faster acting for immune health.

Known as Rapid-D, the halal-certified and 100 per cent vegetarian capsule product contains ampli-D – a form of vitamin D3 known as calcifediol and is a trademarked ingredient by DSM.

The product is sold in a box of 30 capsules in selected general practitioner and specialist clinics, as well as the retail pharmacies of Ng Teng Fong General Hospital and Singapore General Hospital.

New Zealand blackcurrant specialist sets sights on China’s healthy ageing market

The cGP Lab Ltd, a New Zealand firm specialising in developing dietary supplements containing cyclic glycine-proline (cGP) – a molecule extracted from New Zealand grown blackcurrants – is eyeing China’s healthy ageing market with its products.

The company currently sells cGPMAX Brain Health capsules – a dietary supplement that claims to support brain function and is also working on new products containing cGP trademarked cGPMAX, but with different functionalities.

As part of its growth plans, the firm would be selling the products into China via cross-border e-commerce (CBEC) in Tmall Global store early next year.

Net zero ambitions: Nestle launches China’s first carbon-neutral toddler formula

Nestle has launched China’s first carbon-neutral product, a stage three formula for toddlers said to be sourced from Switzerland-based farms that do not use herbicides and growth hormones.

Known as Organic NAN 3, the tin lid and scoop of the product is also said to be made using plant-based materials.

Each tin, which comes in 800g, is said to offset 14.2kg of carbon emission.

Nestle launches China’s first FSMP for patients suffering from tumour-related conditions

Nestle has launched China’s first Foods for Special Medical Purpose (FSMP) for patients suffering from tumour related conditions, after going through a five-year long approval process from the Chinese regulator.

Known as Oral Impact Su Yi Su, the product is also the only FSMP specially approved for nutritional supplementation in this group of patients currently.

Containing arginine and fish oil omega-3 on top of other basic nutritional ingredients, it was formulated to address the problem of inflammation and compromised immunity in patients.

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 08-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Related suppliers

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast